This article refers to:
Correction to: Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma
Richardson PG, Laubach JP, Lonial S, et al. Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma. Expert Rev Anticancer Ther 2015:15(7):737-48
Following publication of this article, it was identified that the affiliation for Prof Jesus San-Miguel was incorrect. The affiliation should be as given below:
Clínica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain.